News

Pfizer/Arvinas to seek FDA nod for jointly developed cancer therapy in H2
Pfizer (PFE) and Arvinas (ARVN) aim to seek FDA approval for thier breast cancer therapy vepdegestrant in H2 2025. Read more ...